Shengquan Tang

Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol

Yanming Zeng, Xiao-Lei Xu, Xiaoqing He et al. · Chinese Medical Journal · 2020 · 62 citations · Full text

No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study

Yin-Qiu Huang, Shengquan Tang, Xiao-Lei Xu et al. · Frontiers in Pharmacology · 2020 · 54 citations · Full text

Pretreatment drug resistance in people living with HIV: A large retrospective cohort study in Chongqing, China

Min Liu, Xiaoqing He, Renni Deng et al. · HIV Medicine · 2022 · 19 citations · Full text

Changes of human immunodeficiency virus (HIV) burden globally and in China over three decades: a secondary analysis of global HIV statistics

Yanqiu Lu, Shengquan Tang, Yuanyuan Qin et al. · Chinese Medical Journal · 2022 · 14 citations · Full text